Oliveira A, Pereira J, Nunes G, Sousa Junior I, Sarmento D, Lopes J
Braz J Infect Dis. 2025; 29(2):104508.
PMID: 39922051
PMC: 11848753.
DOI: 10.1016/j.bjid.2025.104508.
Baena J, Perez L, Toro-Pedroza A, Kitawaki T, Loukanov A
Int J Mol Sci. 2024; 25(23).
PMID: 39684867
PMC: 11642191.
DOI: 10.3390/ijms252313157.
Gupta C, Mundan N, Das S, Jawed A, Dar S, Dailah H
Diagnostics (Basel). 2024; 14(22).
PMID: 39594189
PMC: 11592488.
DOI: 10.3390/diagnostics14222523.
Leung K, Ho P, Wong S, Chan W, Hon K
Curr Pediatr Rev. 2024; 21(2):174-185.
PMID: 38275025
DOI: 10.2174/0115733963264717231208114248.
Sourisseau M, Faure E, Behal H, Chauvet P, Srour M, Capes A
Blood Adv. 2022; 7(5):856-865.
PMID: 36350752
PMC: 9986711.
DOI: 10.1182/bloodadvances.2022008667.
A Predicted Model for Refractory/Recurrent Cytomegalovirus Infection in Acute Leukemia Patients After Haploidentical Hematopoietic Stem Cell Transplantation.
Shen M, Hong S, Wang J, Zhang X, Xu L, Wang Y
Front Cell Infect Microbiol. 2022; 12:862526.
PMID: 35392613
PMC: 8981086.
DOI: 10.3389/fcimb.2022.862526.
Scheduled administration of virus-specific T cells for viral prophylaxis after pediatric allogeneic stem cell transplant.
Rubinstein J, Lutzko C, Leemhuis T, Zhu X, Pham G, Ray L
Blood Adv. 2022; 6(9):2897-2907.
PMID: 35108727
PMC: 9092421.
DOI: 10.1182/bloodadvances.2021006309.
A Meal Replacement Program for the Treatment of Obesity: A Cost-Effectiveness Analysis from the Swiss Payer's Perspective.
Nuijten M, Dainelli L, Rasouli B, Araujo Torres K, Perugini M, Marczewska A
Diabetes Metab Syndr Obes. 2021; 14:3147-3160.
PMID: 34267531
PMC: 8275158.
DOI: 10.2147/DMSO.S284855.
A Systematic Review of the Clinical Pharmacokinetics, Pharmacodynamics and Toxicodynamics of Ganciclovir/Valganciclovir in Allogeneic Haematopoietic Stem Cell Transplant Patients.
Selby P, Shakib S, Peake S, Warner M, Yeung D, Hahn U
Clin Pharmacokinet. 2021; 60(6):727-739.
PMID: 33515202
DOI: 10.1007/s40262-020-00982-z.
Scoring system for clinically significant CMV infection in seropositive recipients following allogenic hematopoietic cell transplant: an SFGM-TC study.
Beauvais D, Drumez E, Blaise D, Peffault de Latour R, Forcade E, Ceballos P
Bone Marrow Transplant. 2020; 56(6):1305-1315.
PMID: 33339900
DOI: 10.1038/s41409-020-01178-6.
Unknown cytomegalovirus serostatus in primary immunodeficiency disorders: A new category of transplant recipients.
Forlanini F, Dara J, Dvorak C, Cowan M, Puck J, Dorsey M
Transpl Infect Dis. 2020; 23(2):e13504.
PMID: 33169931
PMC: 8287897.
DOI: 10.1111/tid.13504.
Emerging Approaches for Regulation and Control of CAR T Cells: A Mini Review.
Brandt L, Barnkob M, Michaels Y, Heiselberg J, Barington T
Front Immunol. 2020; 11:326.
PMID: 32194561
PMC: 7062233.
DOI: 10.3389/fimmu.2020.00326.
Standardized monitoring of cytomegalovirus-specific immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantation.
Wagner-Drouet E, Teschner D, Wolschke C, Janson D, Schafer-Eckart K, Gartner J
Haematologica. 2019; 106(2):363-374.
PMID: 31879324
PMC: 7849569.
DOI: 10.3324/haematol.2019.229252.
Metagenomic Next-Generation Sequencing for Identification and Quantitation of Transplant-Related DNA Viruses.
Carpenter M, Tan S, Watson T, Bacher R, Nagesh V, Watts A
J Clin Microbiol. 2019; 57(12).
PMID: 31554674
PMC: 6879295.
DOI: 10.1128/JCM.01113-19.
CMV Management with Specific Immunoglobulins: A Multicentric Retrospective Analysis on 92 Allotransplanted Patients.
Malagola M, Greco R, Santarone S, Natale A, Iori A, Quatrocchi L
Mediterr J Hematol Infect Dis. 2019; 11(1):e2019048.
PMID: 31528314
PMC: 6736170.
DOI: 10.4084/MJHID.2019.048.
A clinical approach to respiratory disease in patients with hematological malignancy, with a focus on respiratory infection.
Periselneris J, Brown J
Med Mycol. 2019; 57(Supplement_3):S318-S327.
PMID: 31292655
PMC: 7107627.
DOI: 10.1093/mmy/myy138.
Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy.
Restelli U, Croce D, Pacelli V, Ciceri F, Girmenia C
Infect Drug Resist. 2019; 12:1127-1138.
PMID: 31190905
PMC: 6512572.
DOI: 10.2147/IDR.S196282.
Cytomegalovirus Infections after Hematopoietic Stem Cell Transplantation: Current Status and Future Immunotherapy.
Cho S, Lee D, Kim H
Int J Mol Sci. 2019; 20(11).
PMID: 31151230
PMC: 6600658.
DOI: 10.3390/ijms20112666.
VaccHemInf project: protocol for a prospective cohort study of efficacy, safety and characterisation of immune functional response to vaccinations in haematopoietic stem cell transplant recipients.
Conrad A, Boccard M, Valour F, Alcazer V, Tovar Sanchez A, Chidiac C
BMJ Open. 2019; 9(2):e026093.
PMID: 30772864
PMC: 6398679.
DOI: 10.1136/bmjopen-2018-026093.
Cytomegalovirus pneumonia in a patient with T-lymphoblastic leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: A case report.
Li Q, Wang K, Guo W, Lu M
Medicine (Baltimore). 2019; 98(4):e14221.
PMID: 30681598
PMC: 6358403.
DOI: 10.1097/MD.0000000000014221.
